Biden's First 100 Days: What Does It Mean for Life Sciences Companies?
Date & Time
April 29, 2021 1:00 PM - 2:00 PM
Add to Calendar Disabled
Join us for a lively discussion on areas of focus for life sciences companies under the new Biden Administration. We will address several important issues, including:
- How will the Administration incentivize innovation?
- Will the Administration continue to focus on on-shoring medical supplies and devices?
- How will the Administration ensure preparedness for another pandemic?
- Will Medicare be reformed and what could that mean for the drug and device industry?
Byron Dorgan — Senior Policy Advisor, Arent Fox
Jeff Francer — Senior Vice President and General Counsel, Association for Accessible Medicine
Date & Time – Thursday, April 29, 2021 | 1:00 PM ET – 2:00 PM ET
Location – Zoom
Questions? Email Cathleen Wissman